Acne is one of the most common skin conditions seen in general practice. Acne vulgaris—the most prevalent form—affects more ...

Acne isn't a single condition. It appears in many forms, affects people at different ages, and can be triggered by a range of ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently completed the pre-New Drug Application (NDA) consultation with China National Medical Products Administration (NMPA) for ...

A sebum-selective 1726-nm laser treatment provides year-long control of moderate-to-severe acne across all skin types, with ...

Ascletis Pharma, Inc. ( ($HK:1672) ) just unveiled an update. Ascletis Pharma Inc. has completed a pre-New Drug Application consultation with the ...

Use of oral spironolactone in women with acne vulgaris was effective and not associated with increased adverse event risk compared with placebo.

Step into your local drugstore and you’ll come across countless cleansers, serums, lotions and masks all promising the same thing: fewer acne breakouts and clearer, smoother skin. Unfortunately, not ...

Your soft drink habit may be negatively impacting your health—especially if you consume it daily. Here's what to know.

Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, TVB-3567, for development in acne SAN MATEO, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.